Michael Hast, PhD

Director, Scientific Strategy
Merz Therapeutics

Poster(s):

• 1329 - Patient characteristics and real-world use of botulinum toxins for treatment of hemifacial spasm
  Friday, February 23, 2024

  5:00 PM – 6:30 PM EDT

• 1330 - Patient characteristics and real-world use of botulinum toxins for treatment of cervical dystonia and blepharospasm
  Friday, February 23, 2024

  5:00 PM – 6:30 PM EDT

• 1331 - Patient characteristics and real-world use of botulinum toxins for treatment of chronic sialorrhea
  Friday, February 23, 2024

  5:00 PM – 6:30 PM EDT